These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34347975)

  • 21. Association between musk antibody concentrations and the myasthenia gravis composite score in 3 patients: A marker of relapse?
    Triplett JD; Hardy TA; Riminton DS; Chu SYK; Reddel SW
    Muscle Nerve; 2019 Sep; 60(3):307-311. PubMed ID: 31177576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-MuSK Antibody-positive Myasthenia Gravis Mimicking Amyotrophic Lateral Sclerosis.
    Furuta N; Ishizawa K; Shibata M; Tsukagoshi S; Nagamine S; Makioka K; Fujita Y; Ikeda M; Yoshimura S; Motomura M; Okamoto K; Ikeda Y
    Intern Med; 2015; 54(19):2497-501. PubMed ID: 26424311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases].
    Aubert S; Salort-Campana E; Franques J; Uzenot D; Pouget J
    Rev Neurol (Paris); 2009 Nov; 165(11):901-10. PubMed ID: 19327804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity.
    Huijbers MG; Vink AF; Niks EH; Westhuis RH; van Zwet EW; de Meel RH; Rojas-García R; Díaz-Manera J; Kuks JB; Klooster R; Straasheijm K; Evoli A; Illa I; van der Maarel SM; Verschuuren JJ
    J Neuroimmunol; 2016 Feb; 291():82-8. PubMed ID: 26857500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.
    Hurst RL; Gooch CL
    Curr Neurol Neurosci Rep; 2016 Jul; 16(7):61. PubMed ID: 27170368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study.
    Tsonis AI; Zisimopoulou P; Lazaridis K; Tzartos J; Matsigkou E; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Behin A; Sharshar T; De Baets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Casasnovas Pons C; Pitha J; Jakubíkova M; Hanisch F; Tzartos SJ
    J Neuroimmunol; 2015 Jul; 284():10-7. PubMed ID: 26025053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma exosomal miR-106a-5p expression in myasthenia gravis.
    Xu H; Bao Z; Liang D; Li M; Wei M; Ge X; Liu J; Li J
    Muscle Nerve; 2020 Mar; 61(3):401-407. PubMed ID: 31889318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral leukocyte microRNAs as novel biomarkers for COPD.
    Wang R; Xu J; Liu H; Zhao Z
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1101-1112. PubMed ID: 28435243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-MuSK antibodies: correlation with myasthenia gravis severity.
    Bartoccioni E; Scuderi F; Minicuci GM; Marino M; Ciaraffa F; Evoli A
    Neurology; 2006 Aug; 67(3):505-7. PubMed ID: 16894117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-neuronal cholinergic activity is potentiated in myasthenia gravis.
    Han B; Zhang C; Liu S; Xia Y; Sun H; Gong Z; Simard AR; Liu Q; Hao J
    BMC Neurol; 2017 Feb; 17(1):28. PubMed ID: 28178923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
    Vincent A; Leite MI
    Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of acetylcholinesterase inhibitors on patients with MuSK antibody positive myasthenia gravis].
    Konishi T; Kousaka M; Yamakawa K; Matsui M; Ohta K
    Rinsho Shinkeigaku; 2009 Oct; 49(10):660-3. PubMed ID: 19999149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine.
    Cavalcante P; Mizrachi T; Barzago C; Scandiffio L; Bortone F; Bonanno S; Frangiamore R; Mantegazza R; Bernasconi P; Brenner T; Vaknin-Dembinsky A; Antozzi C
    Pharmacol Res; 2019 Oct; 148():104388. PubMed ID: 31401213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
    He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
    J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-1933-3p is upregulated in skeletal muscles of MuSK+ EAMG mice and affects Impa1 and Mrpl27.
    Bogatikov E; Lindblad I; Punga T; Punga AR
    Neurosci Res; 2020 Feb; 151():46-52. PubMed ID: 30763589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
    Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
    Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles.
    Kuwabara S; Nemoto Y; Misawa S; Takahashi H; Kawaguchi N; Hattori T
    Acta Neurol Scand; 2007 Feb; 115(2):126-8. PubMed ID: 17212617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.